The only direct, swift and accurate way to measure total blood volume and red blood cell volume in the clinical setting

Read More

Key Features

  • Actionable results with 98% accuracy
  • Quantifies the excess or deficit vs patient-specific ideal
  • Non-invasive, single-venipuncture technique

Latest News

Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor the Daxor BVA-100 Device, Dr. Joseph Feldschuh

New York, NY February 1, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, sadly announced today the death of the Company’s founder and its first President and Chief Executive Officer, Dr. Joseph Feldschuh. Dr Feldschuh, who was working on a part-time basis and responding well treatment for […]

Read More

Daxor Corporation Announces Dividend, Patent Approval, Title Change

New York, NY, November 18, 2016 – Daxor Corporation, an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend for 2016. The Board of Directors has unanimously approved an annual dividend payment of $0.03 per share. This dividend will be paid on Thursday, December 29, 2016 to Daxor shareholders of […]

Read More